Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the National Cancer Institute

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jnci/djv170PMID 26109217PMCID PMC4651105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women

  2014cited by this paper
• Risk factors of symptomatic NSAID‐induced small intestinal injury and diaphragm disease

  2014cited by this paper
• The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial

  2014cited by this paper
• Estimates of benefits and harms of prophylactic use of aspirin in the general population

  2014cited by this paper
• Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

  2013cited by this paper
• Dose–Risk and Duration–Risk Relationships between Aspirin and Colorectal Cancer: A Meta-Analysis of Published Cohort Studies

  2013cited by this paper
• Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.

  2012cited by this paper
• Does aspirin really reduce the risk of colon cancer?

  2012cited by this paper
• Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers

  2012cited by this paper
• The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?

  2011cited by this paper
• Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.

  2011cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

  2011cited by this paper
• Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.

  2011cited by this paper
• Body Mass Index in Early Adulthood and Endometrial Cancer Risk for Mismatch Repair Gene Mutation Carriers

  2011cited by this paper
• Ibuprofen Inhibits Activation of Nuclear β-Catenin in Human Colon Adenomas and Induces the Phosphorylation of GSK-3β

  2011cited by this paper
• Modification of BRCA 1-Associated Breast and Ovarian Cancer Risk by BRCA 1-Interacting Genes

  2011cited by this paper
• A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis

  2011cited by this paper
• Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

  2010cited by this paper
• Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center

  2010cited by this paper
• Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

  2010cited by this paper
• Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

  2010cited by this paper
• Diagnosis and management of Barrett’s oesophagus

  2010cited by this paper
• Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

  2009cited by this paper
• Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

  2009cited by this paper
• Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

  2009cited by this paper
• Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

  2009cited by this paper
• Applied Survival Analysis: Regression Modeling of Time-to-Event Data

  2008cited by this paper
• Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

  2008cited by this paper
• Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

  2008cited by this paper
• Immortal time bias in pharmaco-epidemiology.

  2008cited by this paper
• Aspirin dose and duration of use and risk of colorectal cancer in men.

  2008cited by this paper
• The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

  2008cited by this paper
• Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * †

  2008cited by this paper
• Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps.

  2008cited by this paper
• Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer

  2007cited by this paper
• Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

  2007cited by this paper
• Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

  2007cited by this paper
• Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.

  2006cited by this paper
• Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

  2006cited by this paper
• Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

  2006cited by this paper
• Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.

  2005cited by this paper
• Application of genetics to the prevention of colorectal cancer.

  2005cited by this paper
• A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes

  2005cited by this paper
• Rofecoxib Reduces Polyp Recurrence in Familial Polyposis

  2003cited by this paper
• Interaction revisited: the difference between two estimates

  2003cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Anti-Inflammatories Inhibit Cancer Growth--But How?

  2001cited by this paper
• Cancer research. Anti-inflammatories inhibit cancer growth--but how?

  2001cited by this paper
• [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer].

  2001cited by this paper
• Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Population carrier frequency of hMSH2 and hMLH1 mutations

  2000cited by this paper
• A Note on Robust Variance Estimation for Cluster‐Correlated Data

  2000cited by this paper
• PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption

  1999cited by this paper
• PPAR d Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs

  1999cited by this paper
• Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis.

  1998cited by this paper
• Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment

  1995cited by this paper
• A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden.

  1994cited by this paper
• Regression standard errors in clustered samples

  1994cited by this paper
• Proportional hazards tests and diagnostics based on weighted residuals

  1994cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures.

  1988cited by this paper
• Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

  1988cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper

• Ibuprofen inhibits human sweet taste and glucose detection implicating an additional mechanism of metabolic disease risk reduction

  2025cites this paper
• Association of non-steroidal anti-inflammatory medications and aspirin with colorectal cancer incidence in older adults

  2025cites this paper
• Aspirin-Inspired 6-O-Carboxymethyl-N-Acetylglucosamine: A potent antitumor agent with enhanced efficacy

  2025cites this paper
• Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testing.

  2025cites this paper
• Association of aspirin and ibuprofen use with endometrial cancer risk in the PLCO dataset

  2025cites this paper
• Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs.

  2025cites this paper
• Risk Prediction of Colon Cancer Metastasis and Bioinformatics Analysis of Aspirin Treatment

  2025cites this paper
• Platelet activation, aspirin, and cancer: From basic science to clinical trials.

  2025cites this paper
• Lynch Syndrome: From Multidisciplinary Management to Precision Prevention

  2024cites this paper
• Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome

  2024cites this paper
• Chemoprevention in Inherited Colorectal Cancer Syndromes

  2023cites this paper
• A New Inverse Probability of Selection Weighted Cox Model to Deal With Outcome‐Dependent Sampling in Survival Analysis

  2023influential citation
• Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer

  2023cites this paper
• Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

  2023cites this paper
• First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation

  2023cites this paper
• Colorectal Cancer Chemoprevention: A Dream Coming True?

  2023cites this paper
• Review article: Lynch Syndrome—a mechanistic and clinical management update

  2022cites this paper
• Formulation and Characterization of Doxycycline-Loaded Polymeric Nanoparticles for Testing Antitumor/Antiangiogenic Action in Experimental Colon Cancer in Mice

  2022cites this paper
• Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies

  2022cites this paper
• Lynch Syndrome: From Carcinogenesis to Prevention Interventions

  2022cites this paper
• From the patient to the population: Use of genomics for population screening

  2022cites this paper
• Hereditary Colorectal Cancer Syndromes: Molecular Genetics and Precision Medicine

  2022cites this paper
• Effects of non-steroidal anti-inflammatory drug (ibuprofen) in low and high dose on stemness and biological characteristics of human dental pulp-derived mesenchymal stem cells

  2022cites this paper
• Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships

  2022cites this paper
• Chemoprevention Considerations in Patients with Hereditary Colorectal Cancer Syndromes.

  2022cites this paper
• EVALUATION OF THE EFFECTS OF IBUPROFEN CYTOTOXIC DOSE ON EXPRESSION LEVEL OF EXTRACELLULAR MATRIX DEGRADING MMP-9 AND ANTI-METASTASIS NM23 GENES IN CERVICAL CANCER CELLS

  2022cites this paper
• Immunology of Lynch Syndrome

  2021cites this paper
• Development of a Secure Website to Facilitate Information Sharing in Families at High Risk of Bowel Cancer—The Familyweb Study

  2021cites this paper
• Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases

  2021cites this paper
• Morphological predictors for microsatellite instability in urothelial carcinoma

  2021cites this paper
• MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer

  2021cites this paper
• OP-JNCI210009 841..851

  2021cites this paper
• Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

  2021cites this paper
• Timing of aspirin use in colorectal cancer chemoprevention: a prospective cohort study.

  2021cites this paper
• Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner

  2020cites this paper
• Chemoprevention of Colorectal Cancer.

  2020cites this paper
• A comprehensive in vivo and mathematic modeling-based kinetic characterization for aspirin-induced chemoprevention in colorectal cancer.

  2020cites this paper
• Regular aspirin intake and prognosis of TxN2-3M0 nasopharyngeal carcinoma: A cohort study based on propensity score matching.

  2020cites this paper
• Molecular pathology of Lynch syndrome

  2020cites this paper
• Aspirin sensitizes osimertinib‐resistant NSCLC cells in vitro and in vivo via Bim‐dependent apoptosis induction

  2020cites this paper
• Is a colorectal neoplasm diagnosis a trigger to change dietary and other lifestyle habits for persons with Lynch syndrome? A prospective cohort study

  2020cites this paper
• International Collaboration for Lynch Syndrome

  2020cites this paper
• Updates in Chemoprevention Research for Hereditary Gastrointestinal and Polyposis Syndromes

  2020influential citation
• Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors

  2020cites this paper
• Constitutional mismatch repair deficiency–associated brain tumors: report from the European C4CMMRD consortium

  2019cites this paper
• In Silico Design, Synthesis, and Characterization of Ibuprofen Derivative as Potential Antitumor Agent.

  2019cites this paper
• Health Benefits of Anti-aging Drugs.

  2019cites this paper
• Association of expression of inflammatory response genes and DNA repair genes in colorectal carcinoma

  2019cites this paper
• Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies

  2019cites this paper
• PREDISPONEN AL DESARROLLO DEL CANCER COLORRECTAL HEREDITARY SYNDROMES THAT PREDISPOSE TO COLORECTAL CANCER

  2019cites this paper
• Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome

  2019cites this paper
• Synthesis of Novel Ibuprofen-Tranexamic Acid Codrug: Estimation of The Clinical Activity Against HCT116 Colorectal Carcinoma Cell Line and The Determination of Toxicity Profile Against MDCK Normal Kidney Cell Line

  2019cites this paper
• The Effects of Ibuprofen Cytoxic Dose on caspase-3, -8 and -9 Activity level in cervical cancer (Hela) cells

  2019cites this paper
• Genetic and Environmental Modifiers of Cancer Risk in Lynch Syndrome

  2018cites this paper
• Chemoprävention und Ernährungsfaktoren bei Darmkrebs

  2018cites this paper
• The Colon Cancer Family Registry Cohort

  2018cites this paper
• Carboxymethyl Tamarind Seed Kernel Polysaccharide Formulated into Pellets to Target at Colon

  2018cites this paper
• Alcohol consumption and early-onset risk of colorectal cancer in Japanese patients with Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum

  2018cites this paper
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)

  2018cites this paper
• Recent progress in Lynch syndrome and other familial colorectal cancer syndromes

  2018cites this paper
• Translational Research in Familial Colorectal Cancer Syndromes

  2018cites this paper
• Colorectal Cancer Among Gout Patients Undergoing Colonoscopy

  2018cites this paper
• Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

  2018cites this paper
• Physical activity and the risk of colorectal cancer in Lynch syndrome

  2018cites this paper
• Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention.

  2018cites this paper
• Treatment Strategies in Colorectal Cancer

  2017cites this paper
• Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management

  2017cites this paper
• Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention

  2017cites this paper
• Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice

  2017cites this paper
• Precancer Atlas to Drive Precision Prevention Trials.

  2017cites this paper
• Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.

  2017cites this paper
• Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.

  2017cites this paper
• Functio Laesa: Cancer Inflammation and Therapeutic Resistance.

  2017cites this paper
• Inflammatory potential of the diet and colorectal tumor risk in persons with Lynch syndrome.

  2017cites this paper
• Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment

  2017cites this paper
• Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

  2017cites this paper
• Chemoprevention of colorectal neoplasia

  2017cites this paper
• Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer

  2017cites this paper
• DNA Mismatch Repair and Lynch Syndrome

  2017cites this paper
• LA QUIMIOPREVENCIÓN PARA PACIENTES CON MUTACIONES HEREDITARIAS DE PREDISPOSICIÓN AL CÁNCER

  2017cites this paper
• SINDROMES HEREDITARIOS QUE PREDISPONEN AL DESARROLLO DEL CANCER COLORRECTAL

  2017cites this paper
• Silicon containing ibuprofen derivatives with antioxidant and anti‐inflammatory activities: An in vivo and in silico study

  2017cites this paper
• Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored.

  2016cites this paper
• RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.

  2016cites this paper
• Targeting the serrated pathway of colorectal cancer with mutation in BRAF.

  2016cites this paper
• Germline miRNA DNA variants and the risk of colorectal cancer by subtype

  2016cites this paper
• The role of aspirin in preventing colorectal cancer.

  2016cites this paper
• Inflammatory networks underlying colorectal cancer

  2016cites this paper
• The risk of developing a mismatch repair deficient (dMMR) colorectal cancer (CRC) after undergoing cholecystectomy (CCY)

  2016cites this paper
• Lifetime Physical Activity and the Risk of Colorectal Cancer: A Population-Based Case-Control Study Using Data from the Newfoundland Colorectal Cancer Registry

  2016cites this paper
• The mutational profile and infiltration pattern of murine MLH1-/- tumors: concurrences, disparities and cell line establishment for functional analysis

  2016cites this paper
• Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

  2016cites this paper
• Response: Table 1.

  2015cites this paper
• When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives

  2015cites this paper
• MicroRNAs in cancer therapeutics: “from the bench to the bedside”

  2015cites this paper